Entry |
|
Symbol |
GSK3B
|
Name |
(RefSeq) glycogen synthase kinase 3 beta
|
KO |
|
Organism |
myd Myotis davidii (David's myotis)
|
Pathway |
myd01521 | EGFR tyrosine kinase inhibitor resistance |
myd04550 | Signaling pathways regulating pluripotency of stem cells |
myd04660 | T cell receptor signaling pathway |
myd04662 | B cell receptor signaling pathway |
myd04919 | Thyroid hormone signaling pathway |
myd04932 | Non-alcoholic fatty liver disease |
myd04935 | Growth hormone synthesis, secretion and action |
myd05022 | Pathways of neurodegeneration - multiple diseases |
myd05163 | Human cytomegalovirus infection |
myd05167 | Kaposi sarcoma-associated herpesvirus infection |
|
Brite |
KEGG Orthology (KO) [BR:myd00001]
09130 Environmental Information Processing
09132 Signal transduction
04310 Wnt signaling pathway
102751662 (GSK3B)
04390 Hippo signaling pathway
102751662 (GSK3B)
04151 PI3K-Akt signaling pathway
102751662 (GSK3B)
04150 mTOR signaling pathway
102751662 (GSK3B)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
102751662 (GSK3B)
09150 Organismal Systems
09151 Immune system
04660 T cell receptor signaling pathway
102751662 (GSK3B)
04657 IL-17 signaling pathway
102751662 (GSK3B)
04662 B cell receptor signaling pathway
102751662 (GSK3B)
04062 Chemokine signaling pathway
102751662 (GSK3B)
09152 Endocrine system
04917 Prolactin signaling pathway
102751662 (GSK3B)
04935 Growth hormone synthesis, secretion and action
102751662 (GSK3B)
04919 Thyroid hormone signaling pathway
102751662 (GSK3B)
09156 Nervous system
04728 Dopaminergic synapse
102751662 (GSK3B)
04722 Neurotrophin signaling pathway
102751662 (GSK3B)
09158 Development and regeneration
04360 Axon guidance
102751662 (GSK3B)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102751662 (GSK3B)
09162 Cancer: specific types
05210 Colorectal cancer
102751662 (GSK3B)
05225 Hepatocellular carcinoma
102751662 (GSK3B)
05226 Gastric cancer
102751662 (GSK3B)
05217 Basal cell carcinoma
102751662 (GSK3B)
05215 Prostate cancer
102751662 (GSK3B)
05213 Endometrial cancer
102751662 (GSK3B)
05224 Breast cancer
102751662 (GSK3B)
09172 Infectious disease: viral
05160 Hepatitis C
102751662 (GSK3B)
05162 Measles
102751662 (GSK3B)
05163 Human cytomegalovirus infection
102751662 (GSK3B)
05167 Kaposi sarcoma-associated herpesvirus infection
102751662 (GSK3B)
05165 Human papillomavirus infection
102751662 (GSK3B)
09171 Infectious disease: bacterial
05135 Yersinia infection
102751662 (GSK3B)
09164 Neurodegenerative disease
05010 Alzheimer disease
102751662 (GSK3B)
05020 Prion disease
102751662 (GSK3B)
05022 Pathways of neurodegeneration - multiple diseases
102751662 (GSK3B)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
102751662 (GSK3B)
05415 Diabetic cardiomyopathy
102751662 (GSK3B)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
102751662 (GSK3B)
04932 Non-alcoholic fatty liver disease
102751662 (GSK3B)
04931 Insulin resistance
102751662 (GSK3B)
04934 Cushing syndrome
102751662 (GSK3B)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
102751662 (GSK3B)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:myd01001]
102751662 (GSK3B)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:myd03036]
102751662 (GSK3B)
Enzymes [BR:myd01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.26 tau-protein kinase
102751662 (GSK3B)
Protein kinases [BR:myd01001]
Serine/threonine kinases: CMGC group
GSK family [OT]
102751662 (GSK3B)
Chromosome and associated proteins [BR:myd03036]
Eukaryotic type
Centrosome formation proteins
Kinases and associated factors
102751662 (GSK3B)
|
SSDB |
|
Motif |
|
Other DBs |
|
Position |
Un
|
AA seq |
450 aa
MSGRPRTTSFAESCKPVQQPSAFGSMKVSSALDKKNKTRFPVTKFAGDKDGSKVTTVVAT
PGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK
LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY
QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR
APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE
MNPNYTEFKFPQIKAHPWTKDSSGTGHFNSGVRVFRPRTPPEAIALCSRLLEYTPTARLT
PLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAAST
PTNATAASDANAGDRGQTNNAASASASNST |
NT seq |
1353 nt +upstreamnt +downstreamnt
atgtcagggcggcccagaaccacctcctttgcggagagctgcaagccagtgcagcagcct
tcggcgtttggcagcatgaaagttagcagtgcattggataaaaagaacaagacacggttt
cctgtcactaagtttgcaggagacaaggatggcagtaaggtgaccacagtggtggcaact
cctgggcagggtccagacaggccgcaagaagtcagctatacagacactaaagtgattgga
aatgggtcatttggtgtggtatatcaagccaaactttgtgattcaggagaattggttgcc
atcaagaaagtattgcaagacaagagatttaagaaccgagagctccaaatcatgagaaag
ctagatcactgtaacatagtccgattgcgttatttcttctactcaagtggtgagaagaaa
gatgaggtctatctcaatctggtgctggactatgttccggaaacagtatacagagttgcc
agacactatagtcgagctaaacagacgcttcctgtgatctatgtcaagttgtatatgtat
cagctgtttcgaagtttagcctatattcattcctttggaatctgccatcgggatattaaa
ccacagaacctcttattggaccctgatacagccgtattaaaactctgtgactttggaagt
gcaaagcagctggtccgaggagaacccaatgtttcgtatatctgttctcggtactatagg
gcaccagagttgatctttggagccactgattatacctctagtatagacgtatggtctgca
ggctgtgtgctggctgaactgttgctaggacaaccaatatttccaggggacagtggtgtg
gatcaattggtggaaataatcaaggttctggggacaccaacaagggagcaaattagagaa
atgaacccaaactacacagaattcaaatttcctcaaattaaggcacatccttggactaag
gattcatcaggaacaggacatttcaactcaggagtgcgggtcttccgaccccgaactcca
ccagaggcaattgcactgtgtagccgtctgttggagtatacaccaactgcccgattgaca
ccactggaagcttgtgcacattcattttttgatgaattacgggacccaaatgtcaaacta
ccaaatggacgagacacccctgcactcttcaacttcaccactcaagaactgtccagtaat
ccacctctagctaccattcttattcctcctcatgctcggattcaagcagctgcttcaacc
ccaacaaatgccacagcagcctcagatgctaatgctggagaccgtggacagaccaataac
gctgcttctgcatcagcttccaactccacctga |